Related Experiment Video

Updated: May 9, 2026

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail

Damien Roux1, Stéphane Gaudry, Linda Khoy-Ear

  • 1Institut National de la Santé et de la Recherche Médicale, INSERM U722, Paris, France.

Critical Care Medicine
|July 27, 2013
PubMed
Abstract

Insights

Fungal colonization of the airways in rats promotes bacterial pneumonia by suppressing immune cell function. Antifungal treatment reduced fungal load, improved immune response, and lowered the incidence of bacterial pneumonia.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • Airway fungal colonization, particularly by Candida albicans, can precede and influence bacterial pneumonia development.
  • The immune response to fungal infections, including interferon-gamma (IFN-γ) production, may impact susceptibility to secondary bacterial infections.

Purpose of the Study:

  • To investigate the relationship between Candida albicans colonization and the development of bacterial pneumonia in a rat model.
  • To evaluate the efficacy of antifungal treatment in mitigating bacterial pneumonia risk in the context of fungal colonization.

Main Methods:

  • Experimental investigation using pathogen-free Wistar rats.
  • Rats were intratracheally instilled with Candida albicans to establish fungal colonization.
  • Secondary infection with bacterial species (Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus) was performed, and immune responses, including alveolar macrophage phagocytosis and IFN-γ levels, were assessed. Antifungal treatment effects were evaluated.

Main Results:

  • Candida albicans colonization was persistent and induced a Th1-Th17 immune response characterized by high IFN-γ levels.
  • Airway fungal presence significantly increased the incidence of bacterial pneumonia.
  • Elevated IFN-γ levels inhibited the phagocytosis of bacteria by alveolar macrophages. Antifungal treatment reduced fungal burden, lowered IFN-γ, and decreased bacterial pneumonia prevalence.

Conclusions:

  • Candida albicans airway colonization triggers an immune response that predisposes to bacterial pneumonia by impairing macrophage bacterial clearance.
  • Antifungal therapy is a potential strategy to reduce the risk of secondary bacterial pneumonia in patients with fungal airway colonization.

More Related Videos

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...